Summary:
«Massachusetts-based Luminopia landed an FDA De Novo for its virtual reality digital therapeutic focused on helping children improve amblyopia, commonly called lazy eye.»
Article written by Laura Lovett. Photo by Julia M. Cameron/Pexels.
21|10|2021
Source:
MobiHealthNews
https://www.mobihealthnews.com/news/luminopia-scores-fda-de-novo-vr-treatment-lazy-eye